P/B
0,9
RxSight
RxSight Inc is a commercial-stage medical technology company dedicated towards improving the vision of patients following cataract surgery. It offers intraocular lens technology that enables doctors to customize and optimize visual acuity for patients after cataract surgery. The company operates and manages its business in one reportable segment, the research and development, manufacture and sale of light adjustable lenses and related capital equipment.
RxSight Inc is a commercial-stage medical technology company dedicated towards improving the vision of patients following cataract surgery. It offers intraocular lens technology that enables doctors to customize and optimize visual acuity for patients after cataract surgery. The company operates and manages its business in one reportable segment, the research and development, manufacture and sale of light adjustable lenses and related capital equipment.
$225.6M
Market Cap • 11/12/2026
1997
(29 years)
Founded
2021
(5 years ago)
IPO
NASDAQ
Listing Exchange
United States
Country
Valuation
P/S
1,9
P/EBITDA
—
P/OCF
9,5
P/FCF
12,1
P/E
—
BVPS
6,1
EPS
—
Market Cap
Market Cap
225,6M
EV
-18,8M
EV/Revenue
-0,2
EV/EBITDA
0,3
EV/EBIT
0,3
Payout
Dividend Per Share
0
Dividend Yield
0%
Buyback Yield
-48,6%
Total Yield
-48,6%
Payout
0%
Retained Earnings
-705,2M
Profitability
Gross Margin
76,1%
EBITDA Margin
—
EBIT Margin
—
Net Margin
—
D&A/EBITDA
0%
R&D/Revenue
30,2%
Capex/Revenue
4,1%
Capex/D&A
139,1%
Capex/OCF
21,2%
SBC/OCF
130,4%
% PPE
7%
% Goodwill
0%
ROE
—
ROIC
—
Growth
CAGR Revenue 5Y
44,9%
CAGR Op. Income 5Y
5,8%
CAGR Net Income 5Y
51,6%
CAGR EPS 5Y
-23,4%
Leverage
N.D./EBITDA
4,2
Debt/Equity
0%
Current Ratio
4,2
Quick Ratio
3,6
Interest Coverage
—
Premium
- Unrestricted access
- Unlimited data history
- Analysis videos
- Quarterly highlights
- Customizable financials table
- Ranking
- Discussions
...and much more!